EndoStim prepares FDA PMA submission for neurostim implant
EndoStim announced today that it held a pre-submission meeting with the FDA regarding its implantable neurostimulation treatment for GERD.
Stay updated with breaking news from Endostim System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EndoStim announced today that it held a pre-submission meeting with the FDA regarding its implantable neurostimulation treatment for GERD.
The FDA has granted breakthrough device designation to EndoStim for its implantable device which serves as a treatment option for patients with refractory gastroesophageal reflux disease, according to a manufacturer release. The EndoStim System is a neurostimulation device which is implanted laparoscopically and designed to provide long-term reflux control via automatically delivered mild
EndoStim announced on October 25th that the FDA granted a breakthrough device designation for the company’s implantable neurostimulation treatment for drug refractory gastroesophageal...